These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33798113)

  • 1. Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation.
    Allen LV
    Int J Pharm Compd; 2021; 25(2):131-139. PubMed ID: 33798113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation.
    Allen LV
    Int J Pharm Compd; 2021; 25(3):222-229. PubMed ID: 34125713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations.
    Allen LV
    Int J Pharm Compd; 2023; 27(2):123-139. PubMed ID: 37000138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic evidence review of rates and burden of harm of intravenous admixture drug preparation errors in healthcare settings.
    Hedlund N; Beer I; Hoppe-Tichy T; Trbovich P
    BMJ Open; 2017 Dec; 7(12):e015912. PubMed ID: 29288174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and Severity of Parenteral Nutrition Medication Errors at a Large Children's Hospital After Implementation of Electronic Ordering and Compounding.
    MacKay M; Anderson C; Boehme S; Cash J; Zobell J
    Nutr Clin Pract; 2016 Apr; 31(2):195-206. PubMed ID: 26214511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications.
    Allen LV
    Int J Pharm Compd; 2020; 24(5):397-402. PubMed ID: 32886638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations.
    Allen LV
    Int J Pharm Compd; 2021; 25(1):31-38. PubMed ID: 33503008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational study of accuracy in compounding i.v. admixtures at five hospitals.
    Flynn EA; Pearson RE; Barker KN
    Am J Health Syst Pharm; 1997 Apr; 54(8):904-12. PubMed ID: 9114922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations.
    Allen LV
    Int J Pharm Compd; 2020; 24(4):305-309. PubMed ID: 32649304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities.
    Allen LV
    Int J Pharm Compd; 2020; 24(2):121-126. PubMed ID: 32196475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates.
    Allen LV
    Int J Pharm Compd; 2020; 24(3):215-220. PubMed ID: 32401741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology in Parenteral Nutrition Compounding.
    Curtis C
    Nutr Clin Pract; 2018 Dec; 33(6):796-802. PubMed ID: 29665084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home Parenteral Nutrition and Intravenous Fluid Errors Discovered Through Novel Clinical Practice of Reconciling Compounding Records: A Case Series.
    Murphy MK; Gura KM; Tascione C; Carey AN; Duggan CP; Raphael BP
    Nutr Clin Pract; 2017 Dec; 32(6):820-825. PubMed ID: 28850287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sterile product compounding using an i.v. compounding workflow management system at a pediatric hospital.
    Moniz TT; Chu S; Tom C; Lutz P; Arnold A; Gura KM; Patterson A
    Am J Health Syst Pharm; 2014 Aug; 71(15):1311-7. PubMed ID: 25027539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Admixture Preparation Considerations, Part 7: Stability Issues.
    Allen LV
    Int J Pharm Compd; 2020; 24(6):473-478. PubMed ID: 33217737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved.
    Allen LV
    Int J Pharm Compd; 2020; 24(1):44-50. PubMed ID: 32023216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe practices for compounding of parenteral nutrition.
    Cohen MR
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):14S-19S. PubMed ID: 22383681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues.
    Allen LV
    Int J Pharm Compd; 2021; 25(4):311-317. PubMed ID: 34297694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding.
    Allen LV
    Int J Pharm Compd; 2019; 23(6):478-482. PubMed ID: 31751945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing.
    Boullata JI; Gilbert K; Sacks G; Labossiere RJ; Crill C; Goday P; Kumpf VJ; Mattox TW; Plogsted S; Holcombe B;
    JPEN J Parenter Enteral Nutr; 2014; 38(3):334-77. PubMed ID: 24531708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.